The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A prospective clinical utility study of the impact of the 21-gene recurrence score assay (Oncotype DX) in estrogen receptor positive (ER+) node negative (pN0) breast cancer in academic Canadian centers.
James Ashley Davidson
Consultant or Advisory Role - Genomic Health (U); Genomic Health (U)
Ian Cromwell
No relevant relationships to disclose
Susan Ellard
Consultant or Advisory Role - Genomic Health (U)
Caroline A. Lohrisch
Consultant or Advisory Role - Genomic Health
Karen A. Gelmon
No relevant relationships to disclose
Tamara Nina Shenkier
No relevant relationships to disclose
Diego Villa
No relevant relationships to disclose
Howard John Lim
No relevant relationships to disclose
Sophie Sun
No relevant relationships to disclose
Sara Kristina Taylor
No relevant relationships to disclose
Marianne Taylor
No relevant relationships to disclose
Barbara Czerkawski
Consultant or Advisory Role - Genomic Health
Malcolm Hayes
No relevant relationships to disclose
Diana Ionescu
No relevant relationships to disclose
Janice Pope
No relevant relationships to disclose
Jayne Berube
No relevant relationships to disclose
Carl N. Yoshizawa
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Calvin Chao
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Stuart Peacock
No relevant relationships to disclose
Stephen K. L. Chia
Consultant or Advisory Role - Genomic Health (U)
Research Funding - Genomic Health